Business Description
Getinge AB
NAICS : 339112
ISIN : SE0000202624
Share Class Description:
OSTO:GETI B: Class BCompare
Compare
Traded in other countries / regions
GETI B.Sweden0GZV.UKGNGBY.USAGTN.GermanyGETIB.Mexico IPO Date
1998-02-01Description
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (54% of revenue), surgical workflows (32%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.64 | |||||
| Equity-to-Asset | 0.59 | |||||
| Debt-to-Equity | 0.22 | |||||
| Debt-to-EBITDA | 1.28 | |||||
| Interest Coverage | 14.08 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.89 | |||||
| Beneish M-Score | -2.8 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.1 | |||||
| 3-Year EBITDA Growth Rate | 7.8 | |||||
| 3-Year EPS without NRI Growth Rate | 26.9 | |||||
| 3-Year FCF Growth Rate | -5.1 | |||||
| 3-Year Book Growth Rate | 13.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 1.11 | |||||
| Future 3-5Y Total Revenue Growth Rate | 1.88 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 31.65 | |||||
| 9-Day RSI | 39.27 | |||||
| 14-Day RSI | 43.59 | |||||
| 6-1 Month Momentum % | -25.03 | |||||
| 12-1 Month Momentum % | -3.52 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.84 | |||||
| Quick Ratio | 1.12 | |||||
| Cash Ratio | 0.44 | |||||
| Days Inventory | 149.47 | |||||
| Days Sales Outstanding | 56.72 | |||||
| Days Payable | 47.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.24 | |||||
| Dividend Payout Ratio | 0.54 | |||||
| 3-Year Dividend Growth Rate | 58.7 | |||||
| Forward Dividend Yield % | 2.24 | |||||
| 5-Year Yield-on-Cost % | 5.46 | |||||
| Shareholder Yield % | 0.07 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 46.46 | |||||
| Operating Margin % | 11.88 | |||||
| Net Margin % | 7.24 | |||||
| ROE % | 7.18 | |||||
| ROA % | 4.2 | |||||
| ROIC % | 5.81 | |||||
| ROC (Joel Greenblatt) % | 36.27 | |||||
| ROCE % | 7.55 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 24 | |||||
| Forward PE Ratio | 15.77 | |||||
| PE Ratio without NRI | 24 | |||||
| Shiller PE Ratio | 24.76 | |||||
| Price-to-Owner-Earnings | 30.21 | |||||
| PEG Ratio | 1.33 | |||||
| PS Ratio | 1.74 | |||||
| PB Ratio | 1.67 | |||||
| Price-to-Tangible-Book | 19.07 | |||||
| Price-to-Free-Cash-Flow | 41.38 | |||||
| Price-to-Operating-Cash-Flow | 20.55 | |||||
| EV-to-EBIT | 16.48 | |||||
| EV-to-Forward-EBIT | 12.49 | |||||
| EV-to-EBITDA | 10.15 | |||||
| EV-to-Forward-EBITDA | 8.74 | |||||
| EV-to-Revenue | 1.84 | |||||
| EV-to-Forward-Revenue | 1.76 | |||||
| EV-to-FCF | 43.34 | |||||
| Price-to-Projected-FCF | 1.01 | |||||
| Price-to-Median-PS-Value | 1.2 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.97 | |||||
| Price-to-Graham-Number | 4.54 | |||||
| Earnings Yield (Greenblatt) % | 6.07 | |||||
| Forward Rate of Return (Yacktman) % | 26.37 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Getinge AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 29,756 | ||
| EPS (TTM) (kr) | 7.92 | ||
| Beta | 1.34 | ||
| Volatility % | 38.18 | ||
| 14-Day RSI | 43.59 | ||
| 14-Day ATR (kr) | 4.708298 | ||
| 20-Day SMA (kr) | 195.225 | ||
| 12-1 Month Momentum % | -3.52 | ||
| 52-Week Range (kr) | 174.2 - 275.2 | ||
| Shares Outstanding (Mil) | 272.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Getinge AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Getinge AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Getinge AB Frequently Asked Questions
What is Getinge AB(OSTO:GETI B)'s stock price today?
The current price of OSTO:GETI B is kr192.40. The 52 week high of OSTO:GETI B is kr275.20 and 52 week low is kr174.20.
When is next earnings date of Getinge AB(OSTO:GETI B)?
The next earnings date of Getinge AB(OSTO:GETI B) is 2023-10-23.
Does Getinge AB(OSTO:GETI B) pay dividends? If so, how much?
The Dividend Yield %  of Getinge AB(OSTO:GETI B) is 2.24% (As of Today), Highest Dividend Payout Ratio of Getinge AB(OSTO:GETI B) was 0.91. The lowest was 0.13. And the median was 0.43. The  Forward Dividend Yield % of Getinge AB(OSTO:GETI B) is 2.24%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers